Researchers at Yale and at Johns Hopkins, led by Barry Gordon, M.D., Ph.D., a professor of Therapeutic Cognitive Neuroscience at Johns Hopkins, have found that a simple blood test to measure uric acid, a measure of kidney function, might reveal a risk factor for cognitive problems and dementia in old age.
Takeda and FDA notified healthcare professionals of recent safety data concerning pioglitazone-containing products. The results of an analysis of the manufacturer’s clinical trial database of pioglitazone showed more reports of fractures in female patients taking pioglitazone than those taking a comparator (either placebo or active).
Having both depression and type 2 diabetes increases the risk of death for heart patients. Each factor had been known to increase the risk of heart disease deaths by itself, but together they?re even more deadly.
Knocking out the gene for a peptide associated with insulin secretion protects mice against the harmful effects of a high-fat diet, report researchers at the Salk Institute for Biological Studies. Their findings, detailed in the Proceedings of the National Academy of Sciences, suggest that urocortin 3, a new peptide recently discovered in the insulin secreting cells of the pancreas, plays a role in the increased production of insulin in response to high caloric intake in animals.
Novo Nordisk announced that the European Commission has approved Levemir? (insulin detemir) for once-daily use in combination with oral antidiabetic drugs (OADs).
A new study from Joslin Diabetes Center may shed light on why some people can eat excessive amounts of food and not gain weight or develop type 2 diabetes, while others are more likely to develop obesity and this most common form of diabetes on any diet.
Novartis announced that it has received an “approvable letter” from the US Food and Drug Administration (FDA) for Galvus? (vildagliptin), under review for US approval as a new once-daily oral treatment for patients with type 2 diabetes.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved more convenient patient storage instructions for BYETTA? (exenatide) injection.
University of Minnesota researchers have discovered a variant of a common blood protein, apolipoprotein C1, in people of American Indian and Mexican ancestry that is linked to elevated body mass index (BMI), obesity and Type 2 diabetes.
A new study led by researchers at the McGill University Health Centre (MUHC) has identified four genes that increase the risk of developing type 2 diabetes.